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Aim: To test the feasibility of retroviral mediated RNA interfer- 
ence to stably knockdown the expression of MMP-13 in human 
osteoarthritic (OA) chondrocytes in 3-D cultures. 
Methods: Primary human chondrocytes were efficiently trans- 
duced with amphotyped pSUPER.retro moloney retroviruses har- 
boring Hu MMP-13 specific short hairpin RNAs (OE7 and OE16). 
Chondrocytes, obtained from 7 patients undergoing knee arthro- 
plasty were infected at their first passage. To investigate the func- 
tional efficacy of MMP-13 knockdown in a culture model mimick- 
ing differentiated chondrocytes in close contact with their extra- 
cellular matrix, puromycin resistant populations of stably trans- 
duced cells were seeded into micromass cultures. Micromasses 
were either left in basal conditions or stimulated with IL-11~, 
GRO~, SDF-1 or BCA-1. Supernatants were assayed by ELISA to 
measure the concentrations of MMP-13 and of collagen II degra- 
dation products. 
Results: Populations of primary chondrocytes from different pa- 
tients, stably expressing the OE7 and OE16 shRNAs, showed 
greater than 80% MMP-13 knockdown by quantitative real time 
PCR in comparison to the same cells expressing a negative 
control luciferase shRNA (pSUPER.retro GL2). In keeping with 
these data, ELISA quantification of cell supernatants also re- 
vealed strong inhibition of stimulated MMP-13 release and also 
lower basal levels in the OE7 and OE16 compared to the GL2 
control chondrocytes. In keeping with these observations, the re- 
lease of collagen II degradation products was also specifically 
abrogated in the same cells exhibiting penetrant MMP-13 knock- 
down. 
Conclusions: RNA interference technology coupled to efficient 
retroviral delivery is an effective tool to stably silence MMP-13 in 
OA chondrocytes, and thus reduce ECM degradation. Targeting 
either other unwanted matrix degrading enzymes or the signaling 
pathways, which determine their expression may be an effective 
means to limit cartilage destruction. 
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Aim: This study aimed to establish a novel in vivo gene delivery 
system for repair of articular cartilage lesions. 
Growth factors have been used to facilitate cartilage repair. How- 
ever these factors are expensive, require large therapeutic doses, 
may be degraded, diffuse away from the desired location, and/or 
require activation of a latent form. Regional genetically engi- 
neered constructs may circumvent these problems. Gene therapy 
for arthritis has focused on viral vectors to introduce the desired 
gene. Concerns regarding these vectors include insertional muta- 
genesis, difficulty targeting specific tissues, and immunogenicity 
to viral particles. Nonviral gene therapy (naked DNA) is an alter- 
native to viral-mediated gene transfer. 
Methods: Human BMP-2 cDNA was cloned into pc.DNA3(+), 
creating the plasmid "pc.hBMP2". Lipopolysaccharide-free DNA 
was prepared. 1 .Functional expression of BMP-2 was examined 
by transfecting pc.hBMP2 into 293T cells and testing conditioned 
medium for osteogenic differentiation capability, by measuring 
alkaline phosphatase (ALP) activity in W20-17 murine marrow 
cells. 2.Diffusion kinetics of plasmid from collagen sponges in 
synovial fluid under constant agitation was examined. 
3.Osteochondral defects were created in the femoral trochlea of 
skeletally mature rabbits. In each of three rabbits, one defect re- 
ceived a collagen sponge with p.c.b-gal plasmid; the contralateral 
defect received a sponge with control plasmid, to show that naked 
DNA is taken up and expressed in this model. Histological sec- 
tions prepared at 1 week were immunostained with antibody to 
b-gal. 4.Defects, created as above, were treated with one of four 
implants: collagen sponge only (N = 9);sponge containing con- 
trol plasmid (N = 12); sponge containing p.c.hBMP-2 (N = 12); 
or sponge containing rhBMP-2 protein (N = 12). Animals were 
sacrificed at 12 weeks and histology prepared. 
Results: ALP activity in W20-17 cells increased in response 
to conditioned medium. A continuous slow diffusion of plasmid 
DNA from the sponge was seen for 18 hr, at which time the 
sponge retained > 98% of the plasmid DNA. Histology showed 
mesenchymal-appearing cells deep to the defect expressing b- 
gal at 1 week after implantation. Differentiated bone cells, chon- 
drocytes, and synoviocytes were unstained. Lesions treated with 
pc.hBMP2 plasmid induced hyaline-like cartilage repair (score 
18.8 4- 3.8) nearly equivalent in quality to that induced by col- 
lagen sponges with recombinant BMP-2 protein (score 20.3 4- 
2.5). 
Conclusion: The novel gene therapy approach of implanting 
endotoxin-free 'naked' cDNA containing the gene for BMP-2 in 
type I collagen sponges into cartilage defects successfully in- 
duced repair at 12 weeks. Our approach circumvents the risks 
of inflammation and immunogenic response associated with the 
use of viral vectors. Naked plasmid DNA as a vehicle for trans- 
ferring therapeutic genes is a potentially important clinical means 
of facilitating articular cartilage regeneration and is both safe and 
cost-effective. 
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Aim: To compare osteochondral angiogenesis in spontaneous 
OA between man and Dunkin Hartley (DH, susceptible) and 
Strain 13 ($13, less susceptible) guinea pigs. 
Methods: Central weight-bearing portions of human medial tibial 
plateaux (MTP) were obtained at total arthroplasty for OA (n = 
45), or post mortem from people with no macroscopic evidence 
of OA (PM) (n = 14). Right knees were obtained from DH guinea 
pigs aged 3, 6, 9 and 12 months (n = 6 per age) and from $13 
guinea pigs aged 3 (n = 4) and 12 months (n = 3). Vascular den- 
sities (No. vessels breaching osteochondral junction mm -1) were 
